# Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan

> **NCT00351650** · — · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 30 (—)

## Conditions studied

- Type I Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00351650
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07-09
- **Primary completion:** —
- **Final completion:** 2008-02-06
- **Target enrollment:** 30 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351650, "Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00351650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*